Methotrexate in inflammatory bowel disease
- 1 June 2004
- journal article
- review article
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 33 (2) , 407-420
- https://doi.org/10.1016/j.gtc.2004.03.001
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- Clinical Pharmacokinetics of Low-Dose Pulse Methotrexate in Rheumatoid ArthritisClinical Pharmacokinetics, 1996
- Suggested guidelines for monitoring liver toxicity in rheumatoid arthritis patients treated with methotrexate: comment on the article by kremer et alArthritis & Rheumatism, 1994
- The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.Journal of Clinical Investigation, 1993
- Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.BMJ, 1992
- Hepatotoxicity in a rat model caused by orally administered methotrexateHepatology, 1991
- Cytotoxic and Immunologic Effects of Methotrexate in PsoriasisJournal of Investigative Dermatology, 1990
- Efficacy of Low-Dose Methotrexate in Rheumatoid ArthritisNew England Journal of Medicine, 1985
- Methotrexate in Rheumatoid ArthritisNew England Journal of Medicine, 1985
- Treatment of Crohn's Disease with 6-MercaptopurineNew England Journal of Medicine, 1980